Back to Search Start Over

Nitric oxide production and monoamine oxidase activity in cancer patients during interferon-a therapy

Authors :
Fekkes, D. (Durk)
Gool, A.R. (Arthur) van
Bannink, M. (Marjolein)
Sleijfer, S. (Stefan)
Kruit, W.H.J. (Wim)
Holt, B. (Bronno) van der
Eggermont, A.M.M. (Alexander)
Hengeveld, M.W. (Michiel)
Stoter, G. (Gerrit)
Fekkes, D. (Durk)
Gool, A.R. (Arthur) van
Bannink, M. (Marjolein)
Sleijfer, S. (Stefan)
Kruit, W.H.J. (Wim)
Holt, B. (Bronno) van der
Eggermont, A.M.M. (Alexander)
Hengeveld, M.W. (Michiel)
Stoter, G. (Gerrit)
Publication Year :
2009

Abstract

Both increased and decreased nitric oxide (NO) synthesis have been reported in patients treated with interferon-alpha (IFN-alpha). Animal studies showed that IFN-alpha administration results in increased levels of biogenic amines, subsequent activation of monoamine oxidases (MAOs), and finally in a change in NO production due to the H(2)O(2) generated by MAOs. We examined the potential relationship between NO production in plasma and MAO-B activity in platelets of 43 cancer patients during 8 weeks of treatment with IFN-alpha. NO synthesis was quantitated by measuring both the ratio of citrulline and arginine (CIT/ARG-ratio

Details

Database :
OAIster
Notes :
application/pdf, Amino Acids vol. 37 no. 4, pp. 703-708, English
Publication Type :
Electronic Resource
Accession number :
edsoai.ocn929956585
Document Type :
Electronic Resource
Full Text :
https://doi.org/10.1007.s00726-008-0191-x